drugset / Trial / NCT00092755

An Investigational Drug in Patients With Osteoarthritis (0663-073)

NCT00092755

Phase 3 Completed 548 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This study was conducted to assess the safety and tolerability of an investigational drug and to evaluate its effectiveness in the treatment of osteoarthritis of the hip or knee in both men and women.

Timeline

Start
2003-04-09
Primary completion
2003-11-13
Completion
2003-11-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Etoricoxib Small molecule 30 mg
Subject Ibuprofen Small molecule 2400 mg

Indications